Tandem Diabetes Care (TNDM) Interest Expenses (2023 - 2026)

Tandem Diabetes Care has reported Interest Expenses for 4 years, with the latest figure at $2.2 million in Q1 2026.

• For the quarter ending Q1 2026, Interest Expenses rose 18.37% year-over-year to $2.2 million; the trailing twelve-month figure through Mar 2026 stood at $8.2 million (up 11.78% YoY), and the FY2025 full-year result was $7.9 million, up 6.64% from the prior year.
• Interest Expenses for Q1 2026 stood at $2.2 million, up from $2.1 million in the prior quarter.
• The five-year high for Interest Expenses was $4.8 million in Q3 2023, with the low at $1.6 million in Q2 2023.
• Historically, Interest Expenses has averaged $2.1 million across 4 years, with a median of $1.9 million in 2024.
• Annual changes were most pronounced in 2024 — Interest Expenses tumbled 61.47% — and 2026, when it rose 18.37%.
• Tandem Diabetes Care's Interest Expenses stood at $1.8 million in 2023, then increased by 3.16% to $1.9 million in 2024, then rose by 11.56% to $2.1 million in 2025, then climbed by 6.22% to $2.2 million in 2026.
• The last three Interest Expenses figures came in at $2.2 million (Q1 2026), $2.1 million (Q4 2025), and $2.1 million (Q3 2025), per Business Quant data.